Nature Biotechnology 2005 Ken Garber - Abstracts
| Nature Biotechnology 2005 Ken Garber | |||||
| Title | Subject | Authors | |||
|---|---|---|---|---|---|
| First-in-class biologic to enter rheumatoid arthritis fray. | Business | Ken Garber | |||
| New apoptosis drugs face critical test. | Business | Ken Garber, Ann Arbor | |||
| Peptide leads new class of chronic pain drug. | Business | Ken Garber, Ann Arbor | |||
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.